Paxman AB (PXMBF)
3.50
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Paxman EPS Diluted (Quarterly) : -0.0006 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Getinge AB | 0.1611 |
| Xvivo Perfusion AB | 0.1258 |
| Abbott Laboratories | 0.6165 |
| AngioDynamics, Inc. | -0.1944 |
| Alphatec Holdings, Inc. | -0.2201 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.0137M |
| Revenue (Quarterly) | 9.798M |
| Total Expenses (Quarterly) | 9.811M |
| Enterprise Value | 70.80M |
| Gross Profit Margin (Quarterly) | 0.19% |
| Profit Margin (Quarterly) | -0.14% |
| Earnings Yield | -1.40% |
| Normalized Earnings Yield | -1.406 |